A detailed history of Huntington National Bank transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Huntington National Bank holds 83 shares of HRMY stock, worth $2,826. This represents 0.0% of its overall portfolio holdings.

Number of Shares
83
Previous 83 -0.0%
Holding current value
$2,826
Previous $2,000 50.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

BUY
$28.81 - $33.01 $172 - $198
6 Added 7.79%
83 $2,000
Q4 2023

Feb 07, 2024

SELL
$19.2 - $33.78 $76 - $135
-4 Reduced 4.94%
77 $2,000
Q3 2023

Nov 08, 2023

BUY
$31.89 - $39.03 $2,583 - $3,161
81 New
81 $2,000
Q1 2023

May 10, 2023

BUY
$30.8 - $53.92 $7,915 - $13,857
257 Added 64.57%
655 $21,000
Q3 2022

Nov 07, 2022

BUY
$42.06 - $55.45 $16,739 - $22,069
398 New
398 $18,000

Others Institutions Holding HRMY

About Harmony Biosciences Holdings, Inc.


  • Ticker HRMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,161,400
  • Market Cap $2.02B
  • Description
  • Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...
More about HRMY
Track This Portfolio

Track Huntington National Bank Portfolio

Follow Huntington National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Huntington National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Huntington National Bank with notifications on news.